Optic nerve atrophy is a serious eye condition that results from damage to the optic nerve, the vital pathway that transmits visual signals from the eye to the brain. This condition can lead to partial or complete vision loss, affecting daily activities and overall quality of life. Causes may include glaucoma, trauma, infections, genetic disorders,

Inherited Retinal Dystrophies (IRDs) — such as Retinitis Pigmentosa (RP), Leber Congenital Amaurosis (LCA), and cone-rod dystrophy — are a group of genetic conditions that progressively damage photoreceptors or the retinal pigment epithelium, often leading to severe vision loss. Over the past five years, the treatment landscape has shifted from purely supportive care toward targeted,

Optic Nerve Atrophy (ONA) is the disease that destroys the optic nerve, causing vision loss or even blindness. Patients over a number of years had no treatment options besides those geared towards the delay of progression and not reversing the condition. But today there is new hope coming through medical science. With its ability to

Optic Nerve Atrophy (ONA) is a serious eye condition marked by the gradual degeneration of the optic nerve, which carries visual information from the eye to the brain. Damage to the optic nerve can cause partial or complete vision loss, and traditional treatments have limited ability to reverse the damage once it occurs. Recent advances

Optic neuritis is an inflammation of the optic nerve which is the vital component of the eye that sends information from the retina to the deep brain. This condition results in abrupt vision loss, which is frequently one-eyed, and can also present pain, blurred vision, colour shifts, and poor vision in low light. Optic neuritis

Optic atrophy is treated in India using a blend of standard and new methods. Traditional therapies include prescription drugs, food supplements, and coffee vision aids to address signs and symptoms as well as underlying illnesses and signs. Innovative treatments like stem cell therapy for optic atrophy in india and gene therapy are being studied in

Optic atrophy in India presents a multifaceted challenge within the country’s diverse healthcare landscape. This condition, characterized by the degeneration or loss of nerve, which connects the eye to the brain. This condition results in gradual decline in vision, often leading to permanent visual impairment. One significant hurdle is limited awareness of optic atrophy, particularly